| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/19/2000 | CN1048499C Process for preparing appropriate salt of 11 beta-aryl-4-estrene pharmaceutical composition |
| 01/19/2000 | CN1048490C Cyclic derivatives, pharmacecctical compositions containg the same derivatives and their use |
| 01/19/2000 | CN1048484C A process for preparing a composition containing benzoheterocycles |
| 01/18/2000 | US6015913 Heating cocoa beans to loosen shell without roasting nib, winnowing nibs from shells, screw pressing nibs to produce cocoa butter and partially defatted cocoa solids |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015835 Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general |
| 01/18/2000 | US6015834 Administering chelate compound; antiischemic, antiepileptic, and wound healing agents; treating brain and nervous system disorders |
| 01/18/2000 | US6015824 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders |
| 01/18/2000 | US6015822 Antiulcer, antidiarrhea, and antiarrhythmia agents; cardiovascular and gastrointestinal disorders |
| 01/18/2000 | US6015818 Quinoline derivatives as bradykinin agonists |
| 01/18/2000 | US6015569 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 01/18/2000 | CA2001124C Treatment of hypertension |
| 01/18/2000 | CA2001123C Treatment of osteoporosis |
| 01/13/2000 | WO2000002051A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000002050A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000001716A2 Vasculoprotector |
| 01/13/2000 | WO2000001713A2 Diacylglycerol acyl transferase proteins |
| 01/13/2000 | WO2000001702A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001701A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001687A1 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/13/2000 | WO2000001676A1 Potassium channel blocking agents |
| 01/13/2000 | WO2000001670A1 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof |
| 01/13/2000 | WO2000001668A2 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 01/13/2000 | WO2000001666A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 01/13/2000 | WO2000001418A1 Transgene expression in polarized cells |
| 01/13/2000 | WO2000001414A1 Use of texaphyrins in macrophage-mediated disease |
| 01/13/2000 | WO2000001389A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/13/2000 | WO2000001382A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001381A1 Substituted oxygen alicyclic compounds, including methods for synthesis thereof |
| 01/13/2000 | WO2000001380A1 cyclo-oxygenase inhibitor |
| 01/13/2000 | WO2000001375A2 Calcium channel blockers |
| 01/13/2000 | WO1999060125A3 Secreted proteins |
| 01/13/2000 | WO1999055312A3 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 01/13/2000 | WO1999046367A8 Methods of diagnosis and triage using cell activation measures |
| 01/13/2000 | DE19830732A1 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff A composition comprising at least one lipid levels influencing drug |
| 01/13/2000 | DE19830648A1 Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung Glyceroltrinitrathaltige composition, process for their preparation and their use |
| 01/13/2000 | DE19830431A1 Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators |
| 01/13/2000 | CA2658200A1 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 01/13/2000 | CA2356841A1 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof |
| 01/13/2000 | CA2345919A1 Substituted oxygen alicyclic compounds, including methods for synthesis thereof |
| 01/13/2000 | CA2337794A1 Transgene expression in polarized cells |
| 01/13/2000 | CA2336739A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | CA2336714A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/13/2000 | CA2336475A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336448A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336315A1 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/13/2000 | CA2336134A1 Use of texaphyrins in macrophage-mediated disease |
| 01/13/2000 | CA2336054A1 Inhibitors of prenyl-protein transferase |
| 01/12/2000 | EP0970957A1 Diaza-spiro[3,5] nonane derivatives |
| 01/12/2000 | EP0970954A1 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same |
| 01/12/2000 | EP0970950A2 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 01/12/2000 | EP0970223A1 Serine/threonine protein kinase |
| 01/12/2000 | EP0970218A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof |
| 01/12/2000 | EP0970217A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use |
| 01/12/2000 | EP0970213A2 Death domain containing receptor 5 |
| 01/12/2000 | EP0970205A2 Human endosulfine gene |
| 01/12/2000 | EP0970111A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970100A1 Benzimidazole derivatives |
| 01/12/2000 | EP0970095A1 Novel benzimidazole inhibitors of fructose-1,6-bisphosphatase |
| 01/12/2000 | EP0970089A2 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 01/12/2000 | EP0970088A2 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action |
| 01/12/2000 | EP0970082A2 Biazacyclic crf antagonists |
| 01/12/2000 | EP0970073A1 Process for preparing eprosartan |
| 01/12/2000 | EP0970053A1 5-oxysubstituted chinolines and their use as cholesterol ester transfer proteins inhibitors |
| 01/12/2000 | EP0970046A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/12/2000 | EP0970042A1 5-hydroxymethyl-2-aminotetralins as cardiovascular agents |
| 01/12/2000 | EP0970036A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity |
| 01/12/2000 | EP0969877A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/12/2000 | EP0969855A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 01/12/2000 | EP0969827A1 Mixture of primary fatty acids obtained from sugar cane wax |
| 01/12/2000 | EP0969813A2 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 01/12/2000 | EP0781285B1 Fused indole and quinoxaline derivatives, their preparation and use as glutamate antagonists |
| 01/12/2000 | EP0781284B1 Indole-2,3-dione-3-oxime derivatives, their preparation and use |
| 01/12/2000 | EP0639079B1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 01/12/2000 | EP0599968B1 Oxazolidinone derivatives useful as antiarrhythmic and antifibrillatory agents |
| 01/12/2000 | CN1241177A Substed. 4-biphenyl-4-hydroxybutyric acid derivs. as matrix metalloprotease inhibitors |
| 01/12/2000 | CN1240661A Health-care tea |
| 01/12/2000 | CN1048241C Vitamin D analogues, their preparing process, pharmaceutical composition contg. same and use thereof |
| 01/12/2000 | CN1048159C Method for preparing pharmaceutical composition contg. imidazolyl-alkenoic acid |
| 01/11/2000 | US6013814 Vitamin D analogues |
| 01/11/2000 | US6013780 VEGF145 expression vectors |
| 01/11/2000 | US6013678 Administering to a patient suffering from congestive heart failure a therapeutically effective amount of 5,6-diisobutyroyloxy-2-methylaminotetralin or a salt |
| 01/11/2000 | US6013675 Therapeutic substituted guanidines |
| 01/11/2000 | US6013667 Benzenesulfonylamine compounds, process for preparing them and pharmaceutical compositions |
| 01/11/2000 | US6013663 Dithiolan derivatives, their preparation and their therapeutic effect |
| 01/11/2000 | US6013645 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives |
| 01/11/2000 | US6013640 Antiischemic agents |
| 01/11/2000 | US6013630 Using mutant atrial natriuretic factor proteins, fragments, analogs, derivatives and homologs thereof, the nucleic acids encoding these mutant proteins, and modulators of atrial natriuretic factor for treating or preventing ischemic stroke |
| 01/11/2000 | US6013497 Polynucleotide sequence that codes a polypeptide; bactericides |
| 01/11/2000 | US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/11/2000 | CA2018137C L-carnitine magnesium citrate |
| 01/07/2000 | CA2276791A1 Use of adenoviral e4 reading frames to improve expression of a gene of interest |
| 01/06/2000 | WO2000000610A2 Human signal peptide-containing proteins |
| 01/06/2000 | WO2000000599A2 Composition for the induction of apoptosis in target cells |
| 01/06/2000 | WO2000000510A2 Growth factor modulators |
| 01/06/2000 | WO2000000477A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | WO2000000470A1 Amino acid derivatives and drugs containing the same as the active ingredient |
| 01/06/2000 | WO2000000468A1 Thyroid hormone analogues and methods for their preparation |
| 01/06/2000 | WO2000000465A1 Hydrazine derivatives |